Skip to main content
Premium Trial:

Request an Annual Quote

Nasdaq Moves to Delist Response Genetics

NEW YORK (GenomeWeb) – Response Genetics may be delisted from the Nasdaq Capital Market after failing to comply with two requirements to remain listed, the firm disclosed in a document filed with the US Securities and Exchange Commission on Dec. 24.

The Los Angeles-based molecular diagnostics firm said in a Form 8-K that it received a delisting determination letter from Nasdaq on Dec. 19 because it was not in compliance with the minimum bid price of $1.00 requirement for continued listing. The letter also stated that the firm was not eligible for an extension to regain compliance because it did not meet the minimum $2.5 million in stockholders’ equity needed for continued listing.

The firm said it intended to appeal the delisting determination by the Dec. 26 deadline, which would stay a suspension of its securities until a hearing process is completed.

On Dec. 11, Nasdaq sent Response Genetics a letter stating that it did not meet a listing requirement calling for a minimum of $2.5 million stockholders' equity. 

The firm said it expects its common stock to be traded on the Over-the-Counter Bulletin Board if it ceases to be listed on the Nasdaq Capital Market.

The Scan

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.

Clinical Trial Participants, Investigators Point to Importance of Clinical Trial Results Reporting in Canadian Study

Public reporting on clinical trial results is crucial, according to qualitative interviews with clinical trial participants, investigators, and organizers from three provinces appearing in BMJ Open.

Old Order Amish Analysis Highlights Autozygosity, Potential Ties to Blood Measures

Researchers in BMC Genomics see larger and more frequent runs-of-homozygosity in Old Order Amish participants, though only regional autozygosity coincided with two blood-based measures.

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.